Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Hong Kong SAR 1996-2001305492.81.03231872227.3283292.7
China - Qidong 1992-200094830.50.224060.694299.4
China - Shangai 1992-1995299047.50.120020.1298899.9
China - Tianjin 1991-1999321447.20.006060.2320899.8
India - Barshi 1993-20009982.81.010122.09798.0
India - Bhopal 1991-199518983.11.632212613.816386.2
India - Chennai 1990-1999224376.22.453174022710.1201689.9
India - Karunagappally 1991-199711170.31.822154.510695.5
India - Mumbai 1992-1994364761.213.749817451914.2312885.8
Singapore 1993-199745992.41.5751132.844697.2
Republic of Korea - Busan 1996-200187676.79.58330869.879090.2
Republic of Korea - Incheon 1997-200134775.212.142104312.430487.6
Republic of Korea - Seoul 1993-1997135372.810.614376021916.2113483.8
Thailand - Chiang Mai 1993-199710975.20.912002119.38880.7
Thailand - Lampang 1990-200011861.04.250054.211395.8
Thailand - Songkhla 1990-199939983.71.567207819.532180.5
Uganda - Kampala 1993-199719640.30.00142168.218091.8
Zimbabwe - Harare 1993-199714651.48.913021510.313189.7



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period